CA2902841A1 - Methods and compositions for detecting pancreatic cancer - Google Patents

Methods and compositions for detecting pancreatic cancer Download PDF

Info

Publication number
CA2902841A1
CA2902841A1 CA2902841A CA2902841A CA2902841A1 CA 2902841 A1 CA2902841 A1 CA 2902841A1 CA 2902841 A CA2902841 A CA 2902841A CA 2902841 A CA2902841 A CA 2902841A CA 2902841 A1 CA2902841 A1 CA 2902841A1
Authority
CA
Canada
Prior art keywords
pancreatic cancer
protein
level
cancer biomarker
homo sapiens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2902841A
Other languages
English (en)
French (fr)
Inventor
Lewis K. Pannell
Jana ROCKER
Jack DI PALMA
Carlo Contreras
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Creatics LLC
Original Assignee
Creatics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creatics LLC filed Critical Creatics LLC
Publication of CA2902841A1 publication Critical patent/CA2902841A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2902841A 2013-03-13 2014-03-13 Methods and compositions for detecting pancreatic cancer Abandoned CA2902841A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361780574P 2013-03-13 2013-03-13
US61/780,574 2013-03-13
PCT/US2014/026857 WO2014160499A2 (en) 2013-03-13 2014-03-13 Methods and compositions for detecting pancreatic cancer

Publications (1)

Publication Number Publication Date
CA2902841A1 true CA2902841A1 (en) 2014-10-02

Family

ID=50933479

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2902841A Abandoned CA2902841A1 (en) 2013-03-13 2014-03-13 Methods and compositions for detecting pancreatic cancer

Country Status (7)

Country Link
US (3) US20160033511A1 (enExample)
EP (1) EP2972375A2 (enExample)
JP (3) JP6646571B2 (enExample)
AU (3) AU2014243704A1 (enExample)
CA (1) CA2902841A1 (enExample)
HK (1) HK1214652A1 (enExample)
WO (1) WO2014160499A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016096785A1 (en) * 2014-12-19 2016-06-23 F. Hoffmann-La Roche Ag Identification of transglutaminase substrates and uses therefor
US10006915B2 (en) 2014-12-19 2018-06-26 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007070660A2 (en) 2005-12-13 2007-06-21 President And Fellows Of Harvard College Scaffolds for cell transplantation
AU2008231575A1 (en) 2007-03-27 2008-10-02 Immunovia Ab Protein signature/markers for the detection of adenocarcinoma
HRP20200310T1 (hr) 2010-10-06 2020-08-21 President And Fellows Of Harvard College Hidrogelovi koji stvaraju pore pogodni za injekcije, namijenjeni staničnim terapijama na bazi materijala
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
US10226238B2 (en) 2011-09-12 2019-03-12 Creatics Llc Non-invasive methods of detecting target molecules
WO2013152860A2 (en) * 2012-04-11 2013-10-17 Dutalys Gmbh Improved antibody light chains
ES2773895T3 (es) 2012-04-16 2020-07-15 Harvard College Composiciones de sílice mesoporosa para modular las respuestas inmunitarias
SG11201408651TA (en) 2012-06-27 2015-01-29 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
ME02865B (me) 2013-03-15 2018-04-20 Shire Viropharma Inc C1-inh kompozicije za upotrebu u prevenciji i liječenju naslednog angioedema (hae)
PT3387898T (pt) 2013-03-15 2020-06-17 Mayo Found Medical Education & Res Identificação e monitorização de imunoglobulinas monoclonais pela massa molecular
CA2952390A1 (en) * 2013-06-20 2014-12-24 The Trustees Of The University Of Pennsylvania Methods for diagnosing pancreatic cancer
JP6759104B2 (ja) 2014-04-04 2020-09-23 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 精密分子質量を用いた免疫グロブリンのアイソタイピング
CN107073090A (zh) 2014-04-30 2017-08-18 哈佛学院董事会 结合的疫苗装置和杀死癌细胞的方法
EP3151008A4 (en) * 2014-05-26 2017-11-22 Olympus Corporation Pancreatic cancer determination method
KR20160045547A (ko) * 2014-10-17 2016-04-27 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
KR102657306B1 (ko) 2014-12-08 2024-04-12 버그 엘엘씨 전립선암의 진단 및 치료에서 필라민을 포함하는 마커의 용도
WO2016123573A1 (en) 2015-01-30 2016-08-04 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
US20160271120A1 (en) * 2015-03-17 2016-09-22 Oakdene Holdings Llc Pharmaceutical composition for cleansing of the gastrointestinal tract
GB201505654D0 (en) * 2015-04-01 2015-05-13 Nordic Bioscience As Immunoassay for collagen type VI sequence
US20180306788A1 (en) * 2015-04-07 2018-10-25 President And Fellows Of Harvard College Compositions and methods for modulating hydroxylation of acc2 by phd3
US11150242B2 (en) 2015-04-10 2021-10-19 President And Fellows Of Harvard College Immune cell trapping devices and methods for making and using the same
US10829560B2 (en) * 2015-04-20 2020-11-10 Consejo Superior De Investigaciones Cientificas Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 RGD motif
HK1254866A1 (zh) 2015-06-25 2019-07-26 Immatics Biotechnologies Gmbh 用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物
GB201511191D0 (en) * 2015-06-25 2015-08-12 Immatics Biotechnologies Gmbh T-cell epitopes for the immunotherapy of myeloma
WO2017036369A1 (en) * 2015-09-03 2017-03-09 The University Of Hong Kong A monoclonal antibody for predicting tamoxifen response in breast cancer patients
JP6968058B2 (ja) 2015-09-24 2021-11-17 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 質量分析法による免疫グロブリン遊離軽鎖の同定
CN105296613A (zh) * 2015-09-24 2016-02-03 郑州市职业病防治院 一种人TERF1基因rs3863242位点多态性检测技术
US11371099B2 (en) 2015-11-30 2022-06-28 Mayo Foundation For Medical Education And Research HEATR1 as a marker for chemoresistance
CN105785013A (zh) * 2016-04-21 2016-07-20 卢连伟 一种辅助检测胰腺癌的胶体金免疫层析试纸及其制备方法
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
JP7075125B2 (ja) * 2016-05-25 2022-05-25 イマティクス バイオテクノロジーズ ゲーエムベーハー 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ
AU2017295704B2 (en) 2016-07-13 2023-07-13 President And Fellows Of Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
CN110418651A (zh) 2016-08-02 2019-11-05 哈佛学院院长等 用于调节免疫应答的生物材料
US10955420B2 (en) 2016-09-07 2021-03-23 Mayo Foundation For Medical Education And Research Identification and monitoring of cleaved immunoglobulins by molecular mass
CN107655985B (zh) * 2017-08-25 2020-05-26 南京农业大学 一种基于lc-ms-ms技术的体内蛋白质营养的评价方法
EP3681528B1 (en) 2017-09-13 2025-07-23 Mayo Foundation for Medical Education and Research Identification and monitoring of apoptosis inhibitor of macrophage
WO2019055632A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J
WO2019195448A1 (en) * 2018-04-03 2019-10-10 Creatics Llc Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples
WO2020061129A1 (en) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions and methods for labeling and modulation of cells in vitro and in vivo
WO2020101878A2 (en) * 2018-10-29 2020-05-22 The Johns Hopkins University Rasopathy treatment
JP2022514568A (ja) 2018-12-17 2022-02-14 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫系のモジュレーションのための生物工学的スキャフォールドおよびその使用
WO2020223646A1 (en) * 2019-05-02 2020-11-05 Creatics Llc Methods for cancer detection by evaluation of alpha-1-antitrypsin (aat) and chymotrypsin-like elastase in gastrointestinal lavage fluid samples
EP3987050A1 (en) * 2019-06-24 2022-04-27 Urteste S.A. Novel diagnostic marker for pancreatic cancer
JP2022549270A (ja) 2019-09-23 2022-11-24 プレジデント アンド フェローズ オブ ハーバード カレッジ バイオマテリアルベースの無抗原ワクチンおよびその使用
WO2021076036A1 (en) * 2019-10-18 2021-04-22 Reccan Diagnostics Ab Apparatuses and methods for detection of pancreatic cancer
CN115667938B (zh) * 2020-05-26 2025-08-08 豪夫迈·罗氏有限公司 用于针对定量因子-定性因子比率校验来校准客户质谱仪器的计算机实现方法
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
EP4182458A2 (en) * 2020-07-20 2023-05-24 Dana-Farber Cancer Institute, Inc. Methods and compositions for treatment and prevention of coronavirus infection
EP3981784A1 (en) * 2020-10-07 2022-04-13 Technische Universität Dresden Regulators of cell division
KR102448586B1 (ko) * 2020-10-08 2022-09-27 가톨릭대학교 산학협력단 췌장암 환자의 항암제 치료 반응성 예측용 마커
US12655221B2 (en) 2020-12-08 2026-06-16 Memorial Sloan Kettering Cancer Center Antibodies to galectin-3 and methods of use thereof
CN112461915B (zh) * 2020-12-08 2024-07-12 杭州汇健科技有限公司 一种与药物敏感相关的特征分子筛选、药敏程度检测、细胞亚型检测的方法
JP2024505333A (ja) 2020-12-21 2024-02-06 フリーノム ホールディングス，インク． 結腸細胞増殖障害の早期検出のためのマーカー
EP4291898A1 (en) * 2021-02-12 2023-12-20 Institut National de la Santé et de la Recherche Médicale (INSERM) Method for prognosis and treating a patient suffering from cancer
US20240201166A1 (en) * 2021-04-11 2024-06-20 Vikas Khurana Diagnosis and treatment of congestive colon failure (ccf)
KR20240017937A (ko) * 2021-06-07 2024-02-08 플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 치료제의 표적화된 전달을 위한 조성물 및 방법
GB202108802D0 (en) * 2021-06-18 2021-08-04 Nordic Bioscience As Collagen type XX assay
US12152280B2 (en) 2021-09-20 2024-11-26 Droplet Biosciences, Inc. Drain fluid for diagnostics
CA3232274A1 (en) * 2021-09-20 2023-03-23 Jose P. Zevallos Drain fluid for diagnostics
US12416626B2 (en) 2022-07-22 2025-09-16 Droplet Biosciences, Inc. Methods for evaluating candidate therapy efficacy based on changes in lymphatic fluid biomarkers
WO2024086298A2 (en) * 2022-10-20 2024-04-25 The Johns Hopkins University Hla class i and class ii-restricted t-cell epitopes in pancreatic cancer tissues and uses thereof
US20260234685A1 (en) * 2023-03-30 2026-08-13 Thomas Jefferson University DNA-Dependent Synthesis of RNA by DNA Polymerase Theta Variants
PL450654A1 (pl) * 2024-12-20 2026-06-22 Urteste Spółka Akcyjna Nowe związki i kombinacje związków oraz ich zastosowania jako biomarkery diagnostyczne, zwłaszcza do wykrywania raka trzustki, sposób wykrywania aktywności enzymatycznej, sposób diagnozowania raka trzustki, zestawy zawierające takie związki i kombinacje, zastosowania takich związków i kombinacji w diagnostyce i leczeniu raka trzustki

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59501519A (ja) * 1982-08-09 1984-08-23 セントコ−・インコ−ポレ−テツド 炭水化物抗原決定基のための免疫検定
JPH0673470B2 (ja) * 1986-07-15 1994-09-21 協和醗酵工業株式会社 抗ヒト胃癌単クロ−ン性抗体ａｍｃ−４６２
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US6924153B1 (en) 1997-03-06 2005-08-02 Quidel Corporation Quantitative lateral flow assays and devices
JPH11225800A (ja) * 1998-02-10 1999-08-24 Kureha Chem Ind Co Ltd 体液を用いた癌検出方法及びキット
US6447763B1 (en) * 1998-06-12 2002-09-10 Ian L. Gordon Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
CA2416191A1 (en) * 2000-07-03 2002-01-10 Mochida Pharmaceutical Co., Ltd. Novel lipase
US20050120393A1 (en) * 2001-08-03 2005-06-02 Origene Technologies, Inc. Full-length prostate selective polynucleotides and polypeptides
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
WO2004055519A2 (en) * 2002-12-17 2004-07-01 Sinogenomax Co. Ltd. Specific markers for pancreatic cancer
WO2005053512A2 (en) * 2003-11-26 2005-06-16 Dana-Farber Cancer Institute, Inc. Animal models of pancreatic adenocarcinoma and uses therefor
EP1766412B1 (en) 2004-05-21 2009-04-01 The Institute for Systems Biology Compositions and methods for quantification of serum glycoproteins
US20090155799A1 (en) 2006-03-02 2009-06-18 Yusuke Nakamura Methods for diagnosing pancreatic cancer using reg4 protein
US8673555B2 (en) * 2008-02-15 2014-03-18 Mayo Foundation For Medical Education And Research Detecting neoplasm
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
CA2760735C (en) * 2009-05-04 2016-12-06 F. Hoffmann-La Roche Ag Use of dppiv/seprase as a marker for cancer
WO2011027311A2 (en) * 2009-09-03 2011-03-10 Koninklijke Philips Electronics N.V. Novel tumor markers
US9075059B2 (en) * 2009-11-05 2015-07-07 University Of Virginia Patent Foundation Compositions and methods for detecting plectin-1 as a biomarker for cancer
CN108872579A (zh) * 2010-06-01 2018-11-23 梅坦诺米克斯保健有限公司 用于在受试者中诊断胰腺癌的工具和方法
MX350533B (es) * 2010-08-13 2017-09-08 Somalogic Inc Biomarcadores de cancer pancreatico y usos de los mismos.
WO2012092529A2 (en) * 2010-12-29 2012-07-05 Expression Pathology, Inc. Protein biomarkers of recurrent breast cancer
EP2696202B1 (en) * 2011-04-05 2017-09-06 Olympus Corporation Pancreas test method, and pancreas test kit
US10226238B2 (en) * 2011-09-12 2019-03-12 Creatics Llc Non-invasive methods of detecting target molecules

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016096785A1 (en) * 2014-12-19 2016-06-23 F. Hoffmann-La Roche Ag Identification of transglutaminase substrates and uses therefor
US10006915B2 (en) 2014-12-19 2018-06-26 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
US10788495B2 (en) 2014-12-19 2020-09-29 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
US11268120B2 (en) 2014-12-19 2022-03-08 Roche Sequencing Solutions, Inc. Identification of transglutaminase substrates and uses therefor

Also Published As

Publication number Publication date
US20220128563A1 (en) 2022-04-28
US20190234951A1 (en) 2019-08-01
JP7109008B2 (ja) 2022-08-10
WO2014160499A3 (en) 2015-01-29
WO2014160499A2 (en) 2014-10-02
JP6646571B2 (ja) 2020-02-14
JP2016519285A (ja) 2016-06-30
JP2022141755A (ja) 2022-09-29
AU2022224782A1 (en) 2022-09-22
HK1214652A1 (zh) 2016-07-29
AU2014243704A1 (en) 2015-09-10
AU2020202066B2 (en) 2022-06-02
AU2020202066A1 (en) 2020-04-09
US20160033511A1 (en) 2016-02-04
JP2020091295A (ja) 2020-06-11
EP2972375A2 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
AU2020202066B2 (en) Methods and compositions for detecting pancreatic cancer
US20070292869A1 (en) Compositions and Methods for Analyzing Renal Cancer
US20230063827A1 (en) Methods and Compositions for the Diagnosis of Ovarian Cancer
KR20090034961A (ko) 폐암 진단 검사
US20100216654A1 (en) Biomarkers of prostate cancer and uses thereof
EP2452948B1 (en) New tumor marker
US20220196670A1 (en) Endometrial receptivity determination
KR101388711B1 (ko) 암 진단 마커로서의 보체 ｃ９
Zhang et al. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening
EP3144676B1 (en) Kit comprising antibody specifically binding to complement factor b protein and antibody specifically binding to carbohydrate antigen 19-9 protein for diagnosing pancreatic cancer
US20230145939A1 (en) Marker composition for cancer diagnosis or prognosis based on exosome overexressing gcc2
KR100883530B1 (ko) 대장암 진단용 단백질 마커 아데노실호모시스테이나제 및이에 대한 항체를 포함하는 대장암 진단키트
CN108047327B (zh) 一种检测骨关节炎的生物标志物及其应用
JP4795353B2 (ja) 腫瘍疾患および慢性炎症性腸疾患の診断のための液性バイオマーカーとしてのカルバモイルリン酸合成酵素１（ｃｐｓ１）の使用
US20150004621A1 (en) Biological marker for early cancer detection and methods for cancer detection (bf819)
WO2020223646A1 (en) Methods for cancer detection by evaluation of alpha-1-antitrypsin (aat) and chymotrypsin-like elastase in gastrointestinal lavage fluid samples
KR20180117918A (ko) Mfap5 측정 제제를 포함하는 대장암 진단용 조성물, 키트, 및 이를 이용한 대장암 진단 방법
KR102128251B1 (ko) 아르기닌이 메틸화된 drd2에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
Du et al. Abnormal N-glycosylated CPXM1 promotes gastric cancer metastasis through ITGB2/FAK pathway
AU2014203702B2 (en) New tumor marker
KR20080092490A (ko) 대장암 진단용 단백질 마커 켈그라눌린 ａ와 켈그라눌린 ｂ및 이들 각각에 대한 항체를 포함하는 대장암 진단키트
HK1166329B (en) New tumor marker
HK1166329A (en) New tumor marker

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190304

FZDE Discontinued

Effective date: 20220426

FZDC Discontinued application reinstated

Effective date: 20220721

FZDC Discontinued application reinstated

Effective date: 20220721

FZDC Discontinued application reinstated

Effective date: 20220721

FZDC Discontinued application reinstated

Effective date: 20220721

FZDC Discontinued application reinstated

Effective date: 20220721

FZDC Discontinued application reinstated

Effective date: 20220721

FZDC Discontinued application reinstated

Effective date: 20220721

FZDE Discontinued

Effective date: 20240228